Skip to main content

Guide for consumers - Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard

Guide for consumers - Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard

Guidance,
Publication date

This resource is a guide for consumers about the Australian Commission on Safety and Quality in Health Care's Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard.  The resource includes 8 quality statements about the health care consumers should receive to support the correct use of psychotropic medicines. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

Author
Australian Commission On Safety And Quality In Health Care
Standard
5: Clinical Care
Outcomes
5.3: Safe and quality use of medicines
5.6 Cognitive impairment  
Guide for consumers - Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard

This is not a Commission publication. Any views are those of the author. You are responsible for considering this in context, based on your circumstances and the Aged Care Act 2024 (Cth) requirements. See Terms of Use .